Page last updated: 2024-09-03

peroxynitrous acid and lipoxin a4

peroxynitrous acid has been researched along with lipoxin a4 in 1 studies

Compound Research Comparison

Studies
(peroxynitrous acid)
Trials
(peroxynitrous acid)
Recent Studies (post-2010)
(peroxynitrous acid)
Studies
(lipoxin a4)
Trials
(lipoxin a4)
Recent Studies (post-2010) (lipoxin a4)
3,303211,23083317398

Protein Interaction Comparison

ProteinTaxonomyperoxynitrous acid (IC50)lipoxin a4 (IC50)
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)0.0001
N-formyl peptide receptor 2Homo sapiens (human)0.0119
Nuclear factor NF-kappa-B p100 subunit Homo sapiens (human)0.0001
Transcription factor p65Homo sapiens (human)0.0001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Filep, JG; József, L; Petasis, NA; Serhan, CN; Zouki, C1

Other Studies

1 other study(ies) available for peroxynitrous acid and lipoxin a4

ArticleYear
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Oct-01, Volume: 99, Issue:20

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Cell Nucleus; Cell Survival; Dose-Response Relationship, Drug; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-8; Leukocytes; Lipoxins; Lymphocytes; Neutrophils; NF-kappa B; Peroxynitrous Acid; Ribonucleases; Superoxides; Transcription Factor AP-1

2002